The POU domain transcription factor OCT4 is a key regulator of pluripotency in the early mammalian embryo and is highly expressed in the inner cell mass of the blastocyst. Consistent with its essential role in maintaining pluripotency, Oct4 expression is rapidly downregulated during formation of the trophoblast lineage. To enhance our understanding of the molecular basis of this differentiation event in humans, we used a functional genomics approach involving RNA interference-mediated suppression of OCT4 function in a human ESC line and analysis of the resulting transcriptional profiles to identify OCT4-dependent genes in human cells. We detected altered expression of >1,000 genes, including targets regulated directly by OCT4 either positively (NANOG, SOX2, REX1, LEFTB, LEFTA/EBAF DPPA4, THY1, and TDGF1) or negatively (CDX2, EOMES, BMP4, TBX18, Brachyury [T], DKK1, HLX1, GATA6, ID2, and DLX5), as well as targets for the OCT4-associated stem cell regulators SOX2 and NANOG. Our data set includes regulators of ACTIVIN, BMP, fibroblast growth factor, and WNT signaling. These pathways are implicated in regulating human ESC differentiation and therefore further validate the results of our analysis. In addition, we identified a number of differentially expressed genes that are involved in epigenetics, chromatin remodeling, apoptosis, and metabolism that may point to underlying molecular mechanisms that regulate pluripotency and trophoblast differentiation in humans. Significant concordance between this data set and previous comparisons between inner cell mass and trophectoderm in human embryos indicates that the study of human ESC differentiation in vitro represents a useful model of early embryonic differentiation in humans.
The earliest differentiation event in the mammalian embryo occurs during formation of the blastocyst, when trophoblast cells delaminate away from a residual cluster of undifferentiated cells, the inner cell mass, containing the pluripotent embryonic founder cells . Little is known about regulation at this stage of development in humans because of the ethical considerations associated with experimental use of this scarce tissue. However, with the establishment of pluripotent embryonic cell lines from human blastocysts, it is now possible to consider investigating molecular mechanisms that regulate the first stages in human development in vitro [2, 3].
The POU domain transcription factor Oct4/OCT4 is a critical regulator of pluripotency in the mammalian embryo and is expressed in unfertilized oocytes, the ICM and epiblasts of pregastrulation embryos, and in primordial germ cells [4, –6]. Downregulation of OCT4 expression during trophoblast differentiation and the conversion of mutant embryos lacking Oct4 into exclusively trophoblast-like cells indicates that the transcription factor is required to either establish or maintain pluripotency in the embryo . Suppression of Oct4/OCT4 in ESCs also induces trophoblast-like differentiation, confirming its essential role in maintaining pluripotency and leading to the proposal that an early function of this transcription factor is as a “gatekeeper,” preventing differentiation along the trophoblast lineage [8, –10]. Studies in mouse and human cells indicate that OCT4 is a component of a network of transcription factors, including the homeobox protein NANOG and HMG-box transcription factor SOX2, that cooperatively maintain pluripotency in ESCs [8, 11, , , –15]. In addition, ESCs also require inputs from extrinsic factors to suppress differentiation. However, the apparently distinct growth factor requirements of mouse and human embryonic stem (ES) [16, –18] point to likely variations in how these signals connect to the basic conserved transcriptional regulatory circuits controlling differentiation of pluripotent stem cells .
As an extension to our previous work [9, 20], we modeled the first differentiation event in human embryos in vitro by acutely depleting OCT4 from human ESCs using RNA interference (RNAi)-mediated gene knockdown and examined the resulting changes in global gene expression. Transcriptional changes induced by OCT4 knockdown are expected to include direct targets of the transcription factor, indirectly associated genes linked with pluripotency, and genes activated upon differentiation along the trophoblast lineage. Combining this information with other data sets on core transcriptional regulatory networks controlling pluripotency and trophoblast differentiation [14, 20] should provide additional insights into the molecular events that underlie the earliest differentiation event in the human embryo.
Materials and Methods
Clone Selection and Microarray Fabrication
The selection of the 15,529 cDNA clones and fabrication of the arrays was as previously described .
Human ESCs (H1 clone) were grown under feeder-free conditions as previously described . Cells were adjusted to dissociation with 0.5 mM EDTA in phosphate-buffered saline (PBS), applied to the cells at 37°C for 5–10 minutes, and routinely passaged in this way. Cells were seeded 24 hours before transfections. For microarray analysis, small interfering RNA (siRNA) transfections were carried out in 75-cm2 flasks in triplicate for each siRNA duplex. Cells were seeded at approximately 5 × 106 cells per flask for analysis at 24 hours after siRNA transfection or approximately 2 × 106 cells per flask for analysis at 72 hours after siRNA transfection. For immunohistochemistry, transfections were carried out in six-well plates, and cells were seeded at 2 × 105 cells per well.
Transfections with siRNA
siRNA duplexes were obtained from Dharmacon RNA Technologies (Lafayette, CO, http://www.dharmacon.com) and reconstituted following the manufacturer's guidelines. Sense strand sequences for the siRNA duplexes were as follows: enhanced green fluorescent protein (EGFP), AAG AAC GGC AUC AAG GUG AAC; OCT4–1, AAG GAU GUG GUC CGA GUG UGG; and OCT4-2, Dharmacon siGENOME duplex 1 (D-019591-05-0010).
Triplicate ESC cultures were transfected individually with 80 nM siRNA duplexes using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, http://www.invitrogen.com) lipofection reagent prepared in OptiMEM (Invitrogen) following the manufacturer's instructions. The siRNA/Lipofectamine 2000 complex was added to the cells in the appropriate volume of ESC culture medium. Cells were fed with fresh culture medium 1 hour prior to transfection and following the removal of the transfection reagent. Cells were transfected once only for RNAi analysis after 24 hours. For RNAi analysis at 72 hours, cells were transfected twice; the second transfection was carried out 24 hours after the first transfection.
Cells were lysed and sonicated in 1% SDS buffer. Lysates were electrophoresed on 10% SDS-polyacrylamide gel electrophoresis gels and immunoblotted as described previously . SHP-2 (1:1,000; sc-280; Santa Cruz Biotechnology Inc., Santa Cruz, CA, http://www.scbt.com), OCT4 (1:1,000; sc-5279; Santa Cruz Biotechnology), SOX2 (1:1,000; sc-17320 X; Santa Cruz Biotechnology), NANOG (1:250; 1997; R&D Systems Inc., Minneapolis, http://www.rndsystems.com), and glyceraldehyde-3-phosphate dehydrogenase (1:5,000; 4300; Ambion, Austin, TX, http://www.ambion.com) antibodies were used. Secondary horseradish peroxidase-conjugated antibodies (Amersham Biosciences, Buckinghamshire, U.K., http://www.amersham.com) were used at a 1:5,000 dilution and detected with the enhanced chemiluminescence reagent (Amersham Biosciences).
Cells were fixed with 100% methanol at −20°C for 10 minutes, washed once in PBS, and permeabilized in 100% ethanol at room temperature for 1 minute. Thereafter, the cells were washed twice in PBS and blocked in PBS containing 10% goat serum (Sigma-Aldrich, St. Louis, http://www.sigmaaldrich.com) for 1 hour at room temperature. Primary antibodies for OCT4 (sc-5279) and cytokeratin-18 (sc-6259) were purchased from Santa Cruz Biotechnology and used at 1:100 dilutions in PBS containing 1% goat serum. Alexa Fluor 568 anti-mouse IgG (Invitrogen) secondary antibody was used at a dilution of 1:400 to detect antibody binding. Coverslips were mounted in Mowial (Calbiochem, San Diego, http://www.calbiochem.com) solution with antifade supplemented with 4,6-diamidino-2-phenylindole nuclear stain. All light and fluorescence microscopy was carried out using a Nikon Microphot SA (Tokyo, http://www.nikon.com) microscope and camera.
RNA Isolation and In Vitro Transcription
Total RNA was isolated using TRIzol reagent (Invitrogen) treated with DNase 1 (Promega GmbH, Mannheim, Germany, http://www.promega.com). Messenger RNA amplifications were carried out using the MegaScript T7 High Yield Transcription kit (Ambion) using 3 μg of total RNA as template. The purity, integrity, and concentrations of generated amplified RNA were evaluated using the Nanodrop Bioanalyzer (Nanodrop Technologies, Wilmington, DE, http://www.nanodrop.com/).
Direct Labeling of RNA and Hybridizations
MIAME (Minimum Information About Microarray Experiments) guidelines were adhered to in our experimental design. Three independent labeling (dye swaps, Cy3, and Cy5) reactions per antisense RNA sample pertaining to each biological replicate were carried out using 3 μg of aRNA per reaction. Full details of labeling and hybridization reactions, slide washing, and scanning have been described previously .
Global Data Analysis
Data were normalized in two steps. The first step accounted for the dye effects caused by the difference in Cy3/Cy5 fluorescence labeling in each experimental sample. Here we used the LOWESS method . For each cDNA, we performed statistical tests based on the replicate signals in experiments with EGFP- and OCT4-depleted samples. Three standard tests were used in parallel, Student's t test, the Welch test, and Wilcoxon's rank-sum test . A full description of the normalization process is detailed in the supplemental online Materials and Methods.
Array data were used to test whether entire groups of genes associated with specific pathways show differential expression. Pathways were taken from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (version KEGG2, 01.06.2005, http://www.genome.ad.jp/kegg/). The procedure has been described previously .
Confirmations were carried out on a set of genes using RNA derived from the two independent OCT4 siRNA transfections. The list of primers used, annealing temperatures, genes under investigation, and experimental details are shown in supplemental online Table 5 and supplemental online Materials and Methods.
Identification of Conserved Downstream Targets of OCT4 in Mouse and Human ESCs
Genes differentially expressed 72 hours after OCT4 knockdown were selected from the raw microarray data set on the basis of four independent statistical tests (p value cutoff, .05) yielding sets of approximately 1,104 up- and downregulated genes. HUGO gene symbol IDs for these genes were checked for occurrence in the OCT4-specific target lists generated by Boyer et al.  and Loh et al. . The complete lists of direct and indirect targets are given in supplemental online Tables 6 and 7.
Depletion of OCT4 in Human Embryonic Stem H1 Cells Using siRNA Transfection
To identify factors associated with early stages in human ESC and trophoblast differentiation, we have combined RNAi and microarray based expression profiling to analyze global changes in gene expression induced by suppression of OCT4 function. Triplicate H1 ESC cultures were transfected with either OCT4 or control EGFP siRNA oligonucleotides, and RNA samples were collected at 24 hours, when the very earliest changes in cell morphology resulting from Oct4 knockdown are first apparent, and at 72 hours, when the appearance of enlarged nuclei and flattening of cells predominates within the cultures (Fig. 1A, 1C, 1D). These morphological changes were accompanied by a reduction in the level of the protein as determined by Western blotting (Fig. 1B) and immunocytochemistry (Fig. 1C). In line with previous experiments, OCT4 siRNAs reduced OCT4 protein levels to less than 30% of the EGFP siRNA controls, consistent with transfection efficiency of more than 70% . OCT4 knockdown was also accompanied by a marked increase in expression of the trophectoderm marker cytokeratin 18 and incorporation of the protein into 10-nm filamentous structures typical of an epithelial cell type (Fig. 1D) [20, 23].
Global Expression Analysis
For each of three transfections harvested at 24 and 72 hours, triplicate RNA samples were labeled with either Cy3 or Cy5, including dye swap. Transcription profiles were then generated by using a cDNA microarray (Ensembl Chip) consisting of 15,529 resequenced and annotated clones. The overall correlations between the OCT4 and EGFP RNAi expression data were 0.993 (24 hours) and 0.943 (72 hours), indicating that the expression levels of the vast majority of genes remain unaltered by the procedures. To judge whether a gene is expressed in the respective cells, we computed a background (BG) tag for its signal. This number reflects the proportion of background signal lower than the actual signal . Typically, a BG tag of 0.9 indicates detectable probe signals (Fig. 2B, bottom panel). Using this criterion, we found that 1,038 (6.63%) of genes represented on the chip (probes) were expressed solely at the 24-hour stage, whereas 518 (3.31%) were expressed exclusively at the 72-hour stage, consistent with a restriction of gene expression and therefore developmental competence upon stem cell differentiation . The vast majority of genes were either expressed at both time points (5,923 genes; 37.83%) or not expressed at all (8,178 genes; 52.23%). The full lists of genes expressed solely at 24 and 72 hours after transfection and also at both time points, together with the corresponding ratios, are presented in supplemental online Tables 1, 2, and 3, respectively. For a global overview of the transcriptional changes resulting from the loss of OCT4 function and insights into the physiological state of human ESCs (hESCs) resulting from OCT4 depletion, we combined the expression data at the 24- and 72-hour time points in an online database for interrogating the expression levels of specific genes and their related gene ontologies (http://goblet.molgen.mpg.de/cgi-bin/stemcell/pluripotency.cgi).
To identify genes with altered expression levels as a result of OCT4 knockdown, we compared the 24- and 72-hour replicates, with EGFP knockdown at the same time points using statistical tests for differential expression (described in Materials and Methods). Three distinct tests (Student's t test, the Welch test, and Wilcoxon's rank sum test) were used to minimize individual bias . By adopting this approach, we identified a subset of 1,104 marker genes from the 72-hour time point. Of these marker genes, 399 (36%) were downregulated, and another 705 were upregulated. Both sets of marker genes were at a significance level of .05. For example, among these differentially regulated marker genes are previously characterized downstream targets of OCT4, such as the pluripotency markers NANOG and SOX2 and markers of undifferentiated stem cells ZFP42, LEFTY1, LEFTY2, DPPA4, THY1, FLJ10884, and TDGF1. The negatively regulated genes included EOMES, BMP4, fibroblast growth factor 8 (FGF8), DKK1, HLX1, GATA2, GATA6, ID2, and DLX5, which are implicated in differentiation processes [14, 15], as well as a large number of novel genes. These differentially regulated genes are listed in supplemental online Table 4. Furthermore, we computed Q values for each of the genes to assess statistical significance by the false discovery rate (FDR) . Using an FDR level of 0.05 identifies 721 of the more than 1,104 genes as significant. However, it should be stressed that FDR assessment can also increase the false-negative rate. For example, ID2, a differentiation marker directly regulated by OCT4 (supplemental online Table 6; Fig. 3) and verified as significant by p value computation, was rejected by FDR assessment. At an FDR level of 0.1, all genes were marked significant.
By comparing gene expression profiles from 24- and 72-hour-post-transfection samples, we selected genes that show changes in expression similar to those of the selected key genes OCT4, EOMES, and BMP4. The OCT4 hierarchical cluster is shown in Figure 2C and includes genes already implicated in the maintenance of pluripotency and self-renewal, such as NANOG; markers of undifferentiated stem cells LEFTY1, LEFTY2, DPPA4, and THY1; and novel genes.
To have an overview of negatively regulated downstream targets of OCT4, we repeated the profile analysis for EOMES and BMP4, respectively (supplemental online Figs. 1 and 2). EOMES encodes a T-box containing transcription factor expressed in the trophectoderm of human and mouse blastocyst and has been shown to be required for mouse trophoblast development and mesoderm formation [20, 26, 27]. The gene encoding bone morphogenetic protein 4 (BMP4) is also highly expressed in the human trophectoderm  and has been shown to promote human embryonic stem cell differentiation into trophoblast . The critical trophoblast stem cell regulator CDX2 could not be been included in this analysis because the clone is not represented on our array. Nonetheless, real-time polymerase chain reaction (PCR) analysis showed that its expression is induced upon depletion of OCT4 (Fig. 3).
Included in this set are genes implicated in ESC differentiation, such as (a) the transcription factors ID3, TBX18, GATA6, and HLX1 ; (b) signal transduction pathways crucial for the maintenance of pluripotency, such as WNT (DKK1, FRZB, FZD2), transforming growth factor β (TGFβ) (TGFB2), and FGF (FGF8); and (c) cytoskeletal and extracellular matrix-associated genes, such as MFAP5, COL4A1, KRT14, LOXL4, and CLDN4, which encodes a tight junction protein crucial for trophectoderm formation. These changes in gene expression overlap with those identified in BMP4-treated hESCs  and may reflect the morphological changes seen upon differentiation of hESCs per se and adoption of trophoblast fate (Fig. 1A, 1D).
Expression patterns of a selection of the differentially expressed genes were verified independently using real-time PCR and Western blotting of samples prepared from cells transfected with either of two different OCT4 siRNAs (Fig. 3). The results shown in Figure 3A confirmed the downregulation of key pluripotency-controlling genes, OCT4, SOX2, and NANOG, and ES-associated genes LEFTY1, LEFTY2, TDGF1, DNMT3B, and ZFP42.
Expression of mesodermal (T/Brachyury) and ectodermal (PAX6) markers was also downregulated, re-emphasizing the lineage-restricted differentiation of OCT4-depleted cells. The induction of CDX2 is in agreement with results obtained in mouse and human ESCs [8, 10], but it differs from our previous results with hESCs grown in mouse embryonic fibroblast (MEF)-conditioned medium, presumably reflecting the improved sensitivity of the current reverse transcription (RT)-PCR assays and inherent variability in MEF-conditioned medium preparations . Confirmation of gene expression characteristic of trophoblast lineage is supported by the upregulated expression of key markers, such as EOMES, CDX2, and BMP4 [9, 10, 17, 20]. The list of primer sequences used for this assay is given in supplemental online Table 5. Western blot analysis (Fig. 3B) shows downregulation of the transcription factors NANOG and SOX2 proteins upon OCT4 knockdown, consistent with their cooperation with OCT4 as part of an interdependent core hES transcriptional regulatory circuit [14, 15].
Downstream Targets of OCT4
Our experimental approach will identify both direct and indirect targets downstream of OCT4. To distinguish between these possibilities, we cross-checked the OCT4-regulated genes with the recently compiled set of transcription targets for OCT4, SOX2, and NANOG identified in hESCs using chromatin immunoprecipitation (ChIP) coupled to promoter microarrays and ChIP-pair end diTag (PET) using mouse ESCs [14, 15]. For the analysis, we defined direct targets as those regulated by OCT4 alone or in combination with NANOG and/or SOX2. We found poor overlap between the three data sets, with 60 genes common to our data set and that of Boyer et al. , 49 common to ours and the mouse data set , and nine common to all three data sets (supplemental online Fig. 3). Included in the nine genes are OCT4, NANOG, and SOX2 and the trophoblast inducer EOMES. Interestingly, CDX2 was a conserved target in human  and not mouse .
The list of direct targets of OCT4 in ESCs is given in supplemental online Table 6. An additional 162 are bound by NANOG and/or SOX2 but not by OCT4, indicating that these are regulated indirectly by OCT4 through its regulation of these downstream effectors (supplemental online Table 7).
In line with the finding that OCT4 regulates its own expression and that of other core hES transcription factors [14, 28, 29], it was not surprising that the subset of directly downregulated genes included NANOG, OCT4, SOX2, HMGB2, and NR2F2 (supplemental online Table 6). Interestingly, the promoters for HMGB2, a coactivator of OCT4 activity, and NR2F2, a regulator of OCT4 expression [30, 31], are positively and negatively regulated, respectively, by OCT4 alone. Additional markers of undifferentiated stem cells identified as positively regulated direct targets were LEFTY2, DPPA4, and TDGF1, whereas ZFP42, LEFTY1, and FLJ10884 were classified as indirect targets. As anticipated, components of signal transduction pathways implicated in the maintenance of pluripotency, such as WNT (DKK1, FZD2), TGFβ (NODAL, LEFTY1, LEFTY2, MADH3 ID2 and PITX2), FGF (FGF8 and FGF2), and Hedgehog (PTCH), are regulated by OCT4.
The remaining genes that are either up- or downregulated upon OCT4 knockdown but do not appear in the data sets of Boyer et al.  and Loh  may represent either previously undiscovered novel OCT4/SOX2/NANOG targets or genes regulated by downstream targets of OCT4 other than SOX2 and NANOG or simply not included in the promoter analysis (supplemental online Table 4). Moreover, this set of genes would also be expected to include a large number of genes involved in trophoblast differentiation.
Signaling and Metabolic Pathways Crucial for the Maintenance of Pluripotency
ESC self-renewal and pluripotency requires inputs from extrinsic factors and their downstream effectors . We therefore analyzed the 24- and 72-hour data set for components of signaling pathways by assigning p values using Wilcoxon's matched pair signed rank test to compare groups of genes associated with particular pathways instead of conventional gene-wise analysis . The analysis, summarized in Table 1, identifies changes in key components of the WNT, transforming growth factor (TGF)β, fibroblast growth factor (EGF), mitogen-activated protein kinase, NOTCH, Hedgehog, JAK/STAT, and extracellular matrix signaling pathways, as well as regulators of the cytoskeleton, apoptosis, cell cycle, and metabolic processes, such as oxidative phosphorylation, methionine metabolism, and folate biosynthesis. The list of complete KEGG annotated pathways identified as operative in ESCs is given in supplemental online Table 8.
Table Table 1.. Pathways of which gene components show significant expression changes between the OCT4 and EGFP knockdowns at 72 hours after transfection
TGFβ and BMP Signaling
Consistent with recent reports identifying TGFβ/ACTIVIN/NODAL signaling as critical for maintaining hESC pluripotency [33, –35], expression of NODAL ligand, its coreceptor TDGF1, and the antagonists LEFTY1 and LEFTY2 is reduced following OCT4 knockdown (Fig. 4C). Downregulation of LEFTY1, LEFTY2, and NODAL could result from them being SOX2/NANOG targets (supplemental online Tables 6 and 7) or through loss of autocrine NODAL signaling as hESCs differentiate . In contrast, expression of FST (FOLLISTATIN), a potent ACTIVIN and weak BMP antagonist is significantly upregulated on OCT4 knockdown (Fig. 4B). Since FST transcription can be induced by ACTIVIN A, this might point to increased ACTIVIN signaling triggered by OCT4 depletion, coincident with downregulation of the ACTIVIN A antagonist TDGF1. OCT4 knockdown increases expression of BMP4 and its downstream target gene ID2, as well as reducing its antagonist CHORDIN (Fig. 4A), in line with the observation that BMP4 induces trophoblast differentiation in hESCs .
FGF signaling is known to play an essential role in preventing hESC differentiation [35, 37, 38], and reduced expression of the hESC autocrine factor FGF2 and FGF12 was observed on OCT4 knockdown (Figs. 3, 5A). In contrast, however, expression of FGF8 and the novel FGF-like receptor FGFRL1 was upregulated, indicating that hESC differentiation along the tro-phoblast lineage may involve complex modulation of FGF signaling. It may be significant that a potential NANOG binding site is identifiable within the FGF8 promoter (supplemental online Table 7).
The role of WNT signaling in human ESCs is controversial because of conflicting reports as to its role in ESC self-renewal [39, 40]. Our analysis of this pathway shows that although expression of WNT antagonists DKK1, DKK3, and FRZB increases upon OCT4 knockdown, FRAT2, a GSK3β-interacting positive effector of WNT signaling , is downregulated (Fig. 5C). The presence of OCT4, NANOG, and SOX2 binding sites within the DKK1, FZD2, and FRAT2 promoters indicates that these WNT components are influenced directly by these key stem cell regulators (supplemental online Table 6).
NOTCH and Hedgehog Signaling
Although both these pathways regulate the fate of many types of stem cells, there is currently little evidence for their involvement in controlling the fate of embryonic stem cells . Examination of NOTCH pathway components revealed downregulation of CBF2 and upregulation of NOTCH2, TLE2, DTX4, and HES1 upon OCT4 knockdown (Fig. 5D). TLE2, a transcriptional repressor , is regulated by NANOG and SOX2 (supplemental online Tables 6 and 7). Analysis of Hedgehog (Hh) signaling components showed reduced levels of both PTCH1, a Hh receptor and target for SOX2 and NANOG (supplemental online Table 7), and the Hh-regulated transcriptional repressor GLI3.
Efficient growth of undifferentiated ESCs (self-renewal) requires the inhibition of apoptosis, as well as differentiation ; we therefore screened the data set for differentially expressed apoptosis-related genes (Fig. 5B). Although expression levels of the pro- and antiapoptotic genes BCL2 and BAX did not change, genes encoding the DNA fragmentation factor (DFFA), the apoptosis-inducing factor (PDCD8), and CASPASE 3 were significantly downregulated, whereas NFKBIA and the calpains CAPN6, CAPN1, and CAPNS1 were upregulated on OCT4 knockdown.
Epigenetic Control of Pluripotency and Trophoblast Lineage Specification
Mutant mouse ESCs lacking DNA methyltransferase activity [45, 46], methyl DNA binding protein function , or histone acetylase activity  exhibit impaired differentiation, highlighting the critical role chromatin modification plays in regulating embryonic differentiation. To investigate whether the expression of chromatin and epigenetic modifiers is affected by OCT4 depletion, we identified differentially regulated genes involved in methyl/folate cycle, DNA methylation, methyl DNA binding, and histone modification communication (supplemental online Fig. 4). Downregulation of MAT2A (methionine adenosyltransferase II α) and MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase) was observed at 72 hours of OCT4 depletion (supplemental online Fig. 4A), supporting the involvement of folic acid metabolism in the maintenance of pluripotency . The de novo methyltransferase DNMT3B was downregulated upon OCT4 depletion, contrasting with the maintenance methylase DNMT1, which showed no significant change. The, histone lysine methyltransferase (H3-K4-HMTase) SET7 was dramatically upregulated upon OCT4 knockdown, contrasting with downregulation of the histone lysine methyltransferase EZH2 (H3-K27-HMTase) (supplemental online Fig. 4B). The acetylases H2AFY and H2AFY2 and the deacetylase HDAC6 also show significant upregulation on OCT4 knockdown (supplemental online Fig. 4C, 4D). These expression patterns perhaps indicate that the hES-to-trophoblast transition is accompanied by significant changes in histone acetylation and methylation patterns.
The nonhistone chromatin-associated proteins HMGB1, HMGB3, DPPA4, NASP, chromatin assembly factor 1 (CHAF1A), PHF17, PHF5A, POLE3, and retinoblastoma binding protein 7 (RBBP7) are all significantly downregulated as a consequence of OCT4 depletion (supplemental online Fig. 4B). Of these, HMGB1, DPPA4, and HMGB3 have previously been shown to be highly enriched in undifferentiated stem cells and isolated ICM cells . The RBBP7-encoded protein has been shown to interact with MBD3 and may have a role in the regulation of cell proliferation and differentiation .
Interestingly, we also observed downregulated expression of PARP1 (Fig. 3), which encodes a chromatin-associated enzyme, poly(ADP-ribosyl) transferase, capable of modifying nuclear proteins. This DNA-dependent ribosylation has been shown to regulate cell proliferation, transformation, and differentiation . Indeed, Parp1-deficient mouse embryonic stem cells differentiate more readily into trophoblast-like cells, implying that one of the functions of this protein is to restrict differentiation in this lineage .
Altered expression of imprinted genes was also observed (upregulation of CALCR and GNAS and downregulation of KIP2 and UBE3A; supplemental online Fig. 4E). KIP2 (a cyclin-dependent kinase inhibitor) acts as a key regulator of embryogenesis through regulation of cell cycle by blocking the activity of G1 cyclin/Cdk complexes and the regulation of actin dynamics through binding to LIMK-1 [53, 54]. Differential gene expression of other cell cycle-related genes was also observed (supplemental online Fig. 5), including the upregulation of CDKN2B, a cyclin-dependent kinase inhibitor, and downregulation of CDC25A, which is required for progression from G1 to the S-phase of the cell cycle, consistent with the limited G1 phase and rapid cell cycle characteristic of undifferentiated ESCs [55, 56].
RNAi-Mediated Suppression of OCT4 Function in Human ESCs Recapitulates Primary Differentiation at the Blastocyst Stage of Development
To examine how closely the transcriptomes of an ICM and trophectoderm (TE) cell matches that of an undifferentiated ESC and OCT4 RNAi-mediated trophoblast cell, we compared our current data set with that derived from the blastocyst . We identified potential candidate genes that were overexpressed in the TE- and OCT4-deficient ESCs compared with the ICM and undifferentiated ESCs when a cluster analysis of genes coregulated in the same manner as BMP4 was performed (Fig. 6). Genes upregulated in the TE- as well as the OCT4-depleted hESCs are involved in the organization of the extracellular matrix (PDLIM3), cell growth and differentiation (AKR1C3 and PLXND1), transcriptional regulation (PME-1, MGC11349/ZXDC, and KIAA1245/COAS1), signal transduction processes (ARL7, PIP5K1C, RASL12, ARHGAP8, SELM, and DKK3, an inhibitor of the WNT pathway), and novel genes (KIAA1949, C14orf173, and FLJ20507/TMEM127). We do not present detailed analysis of this data set here for the simple reason that the vast amount of data is beyond the scope of this study. In summary, these results would imply that these TE marker genes could serve as additional factors required for inducing trophoblast differentiation and further propagation of these cells.
The first differentiation event in mammalian development is the formation of the trophectoderm; this event is controlled by antagonism between OCT4 and the trophoblast transcription factors CDX2 and EOMES . To begin dissecting the complex molecular events that underpin this event in humans, we adopted a functional genomics approach using RNAi to suppress OCT4 function in a human ESC line and microarray-based gene expression profiling. The quality of the data set was rigorously tested in several ways, including numerous statistical tests, achieving consistent reproducibility between replicates as measured by the coefficient of variations of intensity for each gene. The data set is therefore qualitative, quantitative, and comprehensive.
Our microarray analysis shows that OCT4 knockdown in hESCs is accompanied by a reduction in overall complexity of gene expression and differential regulation of more than 1,000 genes, many of which are consistent with a loss of pluripotency and specification of the trophoblast lineage. Among the differentially expressed genes, 60 correspond to direct OCT4 targets identified in human ESCs , 49 to targets in mouse ESCs , and nine (including OCT4, SOX2, NANOG, and EOMES) to targets identified as conserved in human and mouse ESCs. An additional set of 162 consists of targets for SOX2 and NANOG, but not OCT4 [14, 15]. This pattern is compatible with OCT4, SOX2, and NANOG constituting an interdependent network, where loss of expression of one factor ultimately leads to the extinction of the others. A differentiation pathway may depend on factor-specific interactions (for example, between OCT4, EOMES, and CDX2 ) or other genes. The overall low overlap may be attributed to the differences in the platforms used (RNAi, ChIP-chip, and ChIP-PET) and also the transcription factor binding sites being mapped. In addition, off-target indirect effects induced by the OCT4-RNAi manipulation in our study and that in the mouse  may have contributed to the disparity between our list of OCT4 targets. Nonetheless, we cannot exclude the possibility of species differences in the mode of regulation of pluripotency and self-renewal of ESCs. Indeed, our analysis of changes in gene expression and gene ontologies highlights the involvement of cell signaling interactions, epigenetic modifications, chromatin remodeling, and metabolic processes in the ES-to-trophoblast transition.
Examination of differentially expressed components of signal transduction pathways supports previous findings demonstrating the importance of TGFβ, BMP, and FGF signaling in regulating hESC differentiation [18, 35]. NODAL, its coreceptor TDGF1, and transcriptional targets, LEFTY1/2 were downregulated upon OCT4 knockdown, whereas the ACTIVIN-regulated antagonist Follistatin was upregulated. This might reflect a switch from NODAL/TDGF1 to ACTIVIN signaling during trophoblast differentiation and would be compatible with the recently reported involvement of ACTIVIN in trophoblast proliferation in mouse [57, 58]. BMP4, an inducer and marker of trophoblast, was upregulated upon OCT4 knockdown within 24 hours. Given the importance of this factor in regulating ESCs from both mouse and human ESCs, it is notable that the BMP4 promoter was not identified as a target of OCT4, nor of SOX2 or NANOG, indicating that the induction could be mediated indirectly . This could entail a cascade involving GATA6, a target of OCT4 and NANOG in hESCs and regulator of BMP4 expression  or NANOG . FGF2 expression is downregulated upon OCT4 knockdown, consistent with FGF signaling blocking hESC differentiation. However, the induction of FGF8 also points to a likely role for this pathway in trophoblast differentiation. Indeed, induction of components of NOTCH signaling upon OCT4 knockdown could mediate aspects of FGF signaling to promote the generation of trophoblast progenitors , in a manner related to that described for neural differentiation in ESCs and somatic progenitor cells [62, 63]. Many signaling pathways regulate cell survival, as well as differentiation, and it was therefore interesting to find that some pro-apoptotic genes, including CASPASE 3, were downregulated on OCT4 knockdown, supporting the notion that ESCs may be inherently poised for apoptosis because of conflict between signals maintaining the balance between self-renewal and differentiation [16, 44].
OCT4 downregulation also had significant effects on expression of epigenetic and chromatin modifiers. The reciprocal expression patterns of the histone lysine methyltransferases SET7 (up) and EZH2 (down), as well as downregulation of the DNA methyltransferase DNMT3B and a number of histone and nonhistone chromatin-associated proteins, suggest that loss of pluripotency is associated with global changes in chromatin organization . These changes may be actively involved in ESC differentiation per se, but they may, in addition, specifically reflect the generation of an extraembryonic cell type.
As anticipated, the list of OCT4-dependent genes includes as yet uncharacterized novel genes that may represent candidates for further investigation into pluripotency and trophoblast differentiation. Our data provide a reference for combining RNAi and functional genomics using human ESCs to study some of the earliest differentiation events of human postimplantation development. This is supported by the finding that the trophoblast marker BMP4 is enriched in both the TE- and the OCT4-depleted cells at both the 24- and 72-hour time points. Furthermore, the global analysis (data not shown) revealed distinct and overlapping expression patterns between the ICM and undifferentiated ESCs, thus implying that the ICM consist of a transit population of pluripotent cells and that cultured ESCs are an in vitro adaptation of these. Alternatively, the differences between the two data sets may be explained by experimental limitations associated with the scarce human embryo material . Detailed analysis and confirmation of these differences are under way and therefore not included here, as they are beyond the scope of the current study. This type of undertaking should also contribute to the construction of a molecular framework that facilitates robust and predicable control of ESC differentiation and their successful and safe application in stem cell-based therapy in the future.
The authors indicate no potential conflicts of interest.
We are grateful to the German Resource Centre for Genome Research (Berlin, Germany), to Dr. Claus Hultschig for printing the slides, and to Dr. David Hay for help with immunofluorescence. This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (DFG-AD 184/4-1), the Biotechnology and Biological Sciences Research Council (T.C.B.) and the Geron Corporation (Y.B.).